List of JWH cannabinoids

From WikiMD's WELLNESSPEDIA

JWH cannabinoids are a series of synthetic cannabinoids that were developed by John W. Huffman, an organic chemist at Clemson University. They are often used in scientific research and have also been sold as designer drugs. The JWH series is named after Huffman's initials.

History[edit]

The JWH series was first synthesized in the 1990s by Huffman and his team in an effort to create a new class of cannabinoid receptor agonists for use in scientific research. The compounds were initially developed to aid in the study of the endocannabinoid system, but have since been used in a variety of other research contexts.

Structure and Function[edit]

JWH cannabinoids are structurally diverse, but all share a common feature: they are able to bind to and activate the cannabinoid receptors in the brain and other tissues. This makes them useful tools for studying the function of these receptors, as well as for exploring potential therapeutic applications of cannabinoids.

List of JWH Cannabinoids[edit]

Some of the most well-known JWH cannabinoids include:

  • JWH-018: One of the first and most infamous of the JWH cannabinoids, JWH-018 is a potent synthetic cannabinoid that has been associated with numerous cases of overdose and adverse reactions.
  • JWH-073: A less potent analogue of JWH-018, JWH-073 is often used in scientific research due to its more manageable effects.
  • JWH-133: A selective CB2 receptor agonist, JWH-133 is often used in research into potential therapeutic applications of cannabinoids.
  • JWH-200: A potent cannabinoid receptor agonist, JWH-200 has been associated with a number of adverse reactions and is often used as a reference compound in research into the toxicology of synthetic cannabinoids.

Legal Status[edit]

Due to their potential for abuse and the health risks associated with their use, many JWH cannabinoids are controlled substances in many countries. In the United States, for example, several JWH cannabinoids are classified as Schedule I controlled substances under the Controlled Substances Act.

See Also[edit]

This article is a stub related to chemistry. You can help WikiMD by expanding it!


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


List of JWH cannabinoids gallery[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.